M. Maxwell et al., OVEREXPRESSION OF THE ROS1 GENE IN PRIMARY HUMAN GLIOMAS MAY CONTRIBUTE TO MALIGNANT PROGRESSION, International journal of oncology, 8(4), 1996, pp. 713-718
Gliomas are malignant brain tumors thought to arise through multi-step
tumorigenesis, involving both the activation of oncogenes and the los
s of tumor suppressor genes. The ros1 gene encodes a proto-oncogenic p
rotein which has been implicated, by in vitro studies, in the pathogen
esis of several types of cancer, including gliomas. Northern blot anal
ysis revealed expression of ros1 mRNA in 3 (30%) of 10 primary glioma
specimens. In situ hybridization localized ros1 mRNA transcripts to GF
AP positive tumor cells and pericytes around capillaries. Immunohistoc
hemistry using an antibody specific for ros1 demonstrated strong posit
ivity amongst neoplastic glial cells in the same glioma samples. No ro
s1 mRNA or protein was detected in 5 normal brain specimens. These dat
a provide the first evidence for the overexpression of ros1 mRNA and p
rotein in primary human gliomas, and are consistent with a proposed on
cogenic role of ros1 in these tumors.